Claudia Caserta

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles, Se Hoon Park, Éric Voog et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

Luis Paz‐Ares, Suresh S. Ramalingam, Tudor–Eliade Ciuleanu et al. · Journal of Thoracic Oncology · 2021 · 318 citations · Full text

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli et al. · Clinical Cancer Research · 2019 · 233 citations · Full text

Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications

Jeffrey Crawford, Claudia Caserta, F. Roila · Annals of Oncology · 2010 · 230 citations · Full text

Bone Marrow Failure, Hematology, Classical Hematology +3

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

Thomas Powles, Se Hoon Park, Claudia Caserta et al. · Journal of Clinical Oncology · 2023 · 192 citations · Full text